Pediatric Annals

Feature Article 

The Multiple Indications for Growth Hormone Treatment of Pediatric Patients

Abstract

EXCERPT

Current Food and Drug Administration-approved uses of growth hormone in children are for treatment of the following conditions: growth hormone deficiency, chronic renal failure, Turner syndrome, Prader-Willi syndrome, small for gestational age, and idiopathic short stature. This article discusses each of these conditions and describes some of their clinical features and the impact of treatment with growth hormone. Growth hormone also has FDA-approved uses in adults, including AIDS wasting and growth hormone deficiency, but these uses are beyond the scope of this review.

ABOUT THE AUTHORS

Rebecca S. Farber, MD, is a Pediatrician at Tenafly Pediatrics, Tenafly, New Jersey. James R. Kerrigan, MD, is Professor of Pediatric Endocrinology at Wake Forest University Health Sciences, Winston-Salem, North Carolina.

Address correspondence to: James R. Kerrigan, MD, Department of Pediatrics, Wake Forest University Health Sciences, Medical Center Boulevard, Winston-Salem, North Carolina 27157, fax: 336-716-9229; jkerriga@wfubmc.edu.

Abstract

EXCERPT

Current Food and Drug Administration-approved uses of growth hormone in children are for treatment of the following conditions: growth hormone deficiency, chronic renal failure, Turner syndrome, Prader-Willi syndrome, small for gestational age, and idiopathic short stature. This article discusses each of these conditions and describes some of their clinical features and the impact of treatment with growth hormone. Growth hormone also has FDA-approved uses in adults, including AIDS wasting and growth hormone deficiency, but these uses are beyond the scope of this review.

ABOUT THE AUTHORS

Rebecca S. Farber, MD, is a Pediatrician at Tenafly Pediatrics, Tenafly, New Jersey. James R. Kerrigan, MD, is Professor of Pediatric Endocrinology at Wake Forest University Health Sciences, Winston-Salem, North Carolina.

Address correspondence to: James R. Kerrigan, MD, Department of Pediatrics, Wake Forest University Health Sciences, Medical Center Boulevard, Winston-Salem, North Carolina 27157, fax: 336-716-9229; jkerriga@wfubmc.edu.

10.3928/0090-4481-20061201-06

Sign up to receive

Journal E-contents